<p>1. Monoamine Transporters: Vulnerable and Vital Doorkeepers<br>Zhicheng Lin, Juan J. Canales, Thröstur Björgvinsson, Morgane M. Thomsen, Hong Qu, Qing-Rong Liu, Gonzalo E. Torres, and S. Barak Caine<br>2. Therapeutic Targets in Alzheimer Disease and Related Tauopathies<br>Christopher P. Corbo and Alejandra del C. Alonso<br>3. Therapeutic Targets for Neuroprotection and/or Enhancement of Functional Recovery Following Traumatic Brain Injury<br>Matthew L. Kelso and James R. Pauly<br>4. Insulin, Synaptic Function, and Opportunities for Neuroprotection<br>John G. Mielke and Yu-Tian Wang<br>5. Molecular Alterations in Glioblastoma: Potential Targets for Immunotherapy<br>Azizul Haque, Naren L. Banik, and Swapan K. Ray<br>6. Molecular Signaling and Translational Significance of the Corticotropin Releasing Factor System<br>Patrick J. Ronan, and Cliff H. Summers<br>7. Molecular targets of alcohol action: translational research for pharmacotherapy development and screening<br>Giorgio Gorini, Richard L. Bell, and R. Dayne Mayfield<br>8. Brain Nicotinic Receptors as Emerging Targets for Drug Addiction: Neurobiology to Translational Research<br>Shafiqur Rahman<br>9. Glutamatergic Neuroplasticity in Cocaine Addiction<br>Joachim D. Uys<SUP> </SUP>and Kathryn J. Reissner<br>10. Role of the serotonergic system in alcohol dependence: from animal models to clinics<br>Verity R. Johnson, Jason M. Weedman, Youssef Sari</p>